Search Results - Filip K. Knop

Refine Results
  1. 1

    A glucose-insulin-glucagon coupled model of the isoglycemic intravenous glucose infusion experiment by Vijaya Subramanian, Jonatan I. Bagger, Jonatan I. Bagger, Jonatan I. Bagger, Jens J. Holst, Jens J. Holst, Filip K. Knop, Filip K. Knop, Filip K. Knop, Filip K. Knop, Tina Vilsbøll, Tina Vilsbøll, Tina Vilsbøll

    Published in Frontiers in Physiology (2022-09-01)
    Get full text
    Article


  2. 2

    Hypoglycaemia and cardiac arrhythmias in diabetes by Andreas Andersen, Peter G. Jørgensen, Filip K. Knop, Tina Vilsbøll

    Get full text
    Article


  3. 3

    Accuracy of continuous glucose monitoring during exercise-related hypoglycemia in individuals with type 1 diabetes by Kaisar Maytham, Kaisar Maytham, Per G. Hagelqvist, Per G. Hagelqvist, Susanne Engberg, Julie L. Forman, Ulrik Pedersen-Bjergaard, Ulrik Pedersen-Bjergaard, Filip K. Knop, Filip K. Knop, Filip K. Knop, Tina Vilsbøll, Tina Vilsbøll, Tina Vilsbøll, Andreas Andersen, Andreas Andersen

    Published in Frontiers in Endocrinology (2024-04-01)
    Get full text
    Article


  4. 4

    Two weeks of acarbose treatment shows no effect on gut microbiome composition in patients with type 2 diabetes: a randomised, placebocontrolled, double-blind, crossover study by Niels B Dalsgaard, Lærke S Gasbjerg, Laura S Hansen, Dennis S Nielsen, Torben S Rasmussen, Filip K Knop

    Published in Endocrine Connections (2024-07-01)
    Get full text
    Article


  5. 5

    Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. by Heidi Storgaard, Lise L Gluud, Cathy Bennett, Magnus F Grøndahl, Mikkel B Christensen, Filip K Knop, Tina Vilsbøll

    Published in PLoS ONE (2016-01-01)
    Get full text
    Article


  6. 6

    Separate and combined effects of long-term GIP and GLP-1 receptor activation in patients with type 2 diabetes: a structured summary of a study protocol for a double-blind, randomis... by Tina Vilsbøll, Filip K Knop, Mads M Helsted, Lærke S Gasbjerg, Casper K Nielsen, Julie L Forman, Mikkel B Christensen

    Published in BMJ Open (2023-02-01)
    Get full text
    Article


  7. 7

    Semaglutide treatment for PRevention Of Toxicity in high-dosE Chemotherapy with autologous haematopoietic stem-cell Transplantation (PROTECT): study protocol for a randomised, doub... by Filip K Knop, Hannelouise Kissow, Maria Ebbesen Sørum, Anne Ortved Gang, Dorte Maegaard Tholstrup, Sif Gudbrandsdottir, Brian Kornblit, Klaus Müller

    Published in BMJ Open (2024-10-01)
    Get full text
    Article


  8. 8

    evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomat... by Jeffrey L. Cummings, Alireza Atri, Howard H. Feldman, Oskar Hansson, Mary Sano, Filip K. Knop, Peter Johannsen, Teresa León, Philip Scheltens

    Published in Alzheimer’s Research & Therapy (2025-01-01)
    Get full text
    Article


  9. 9

    Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion by Nicolai J. Wewer Albrechtsen, Simon Veedfald, Astrid Plamboeck, Carolyn F. Deacon, Bolette Hartmann, Filip K. Knop, Tina Vilsboll, Jens J. Holst

    Published in Journal of Diabetes Research (2016-01-01)
    Get full text
    Article


  10. 10

    Rectal sensitivity correlated with gastrointestinal‐mediated glucose disposal, but not the incretin effect by Sondre Meling, Erling Tjora, Heike Eichele, Rasmus B. Nedergaard, Filip K. Knop, Niels Ejskjaer, Siri Carlsen, Pål R. Njølstad, Christina Brock, Eirik Søfteland

    Published in Endocrinology, Diabetes & Metabolism (2024-01-01)
    Get full text
    Article


  11. 11

    Gluco-metabolic effects of oral and intravenous alcohol administration in men by Amalie R Lanng, Lærke S Gasbjerg, Natasha C Bergmann, Sigrid Bergmann, Mads M Helsted, Matthew P Gillum, Bolette Hartmann, Jens J Holst, Tina Vilsbøll, Filip K Knop

    Published in Endocrine Connections (2019-10-01)
    Get full text
    Article


  12. 12

    No effect of the turmeric root phenol curcumin on prednisolone-induced glucometabolic perturbations in men with overweight or obesity by Pernille H Hellmann, Jonatan I Bagger, Katrine R Carlander, Katrine B Hansen, Julie L Forman, Joachim Størling, Elizaveta Chabanova, Jens Holst, Tina Vilsbøll, Filip K Knop

    Published in Endocrine Connections (2023-04-01)
    Get full text
    Article


  13. 13

    Transcutaneous vagus nerve stimulation has no anti-inflammatory effect in diabetes by Tina Okdahl, Huda Kufaishi, Ditte Kornum, Davide Bertoli, Klaus Krogh, Filip K.Knop, Christian Stevns Hansen, Joachim Størling, Peter Rossing, Birgitte Brock, Asbjørn M. Drewes, Christina Brock

    Published in Scientific Reports (2024-09-01)
    Get full text
    Article


  14. 14

    Hyperglucagonaemia and amino acid alterations in individuals with type 2 diabetes and non-alcoholic fatty liver disease by Iben Rix, Marie L Johansen, Asger Lund, Malte P Suppli, Elizaveta Chabanova, Gerrit van Hall, Jens J Holst, Nicolai J Wewer Albrechtsen, Caroline Kistorp, Filip K Knop

    Published in Endocrine Connections (2023-12-01)
    Get full text
    Article


  15. 15

    Metformin treatment for patients with hand osteoarthritis: protocol for the multicentre, randomised, placebo-controlled METRO trial by David J Hunter, Robin Christensen, Marius Henriksen, Henning Bliddal, Karen Ellegaard, Mikael Boesen, Tue Kragstrup, Filip K Knop, Anna Dossing, Kasper Staberg Madsen, Asbjørn S Poulsen, Rasmus Oscar

    Published in BMJ Open (2025-03-01)
    Get full text
    Article


  16. 16

    Effects of levothyroxine substitution therapy on hunger and food intake in individuals with hypothyroidism by Bjarke R Medici, Birte Nygaard, Jeppe L la Cour, Martin Krakauer, Andreas Brønden, Mette P Sonne, Jens J Holst, Jens F Rehfeld, Tina Vilsbøll, Jens Faber, Filip K Knop

    Published in Endocrine Connections (2023-09-01)
    Get full text
    Article


  17. 17

    The effect of exogenous glucagon on circulating amino acids in individuals with and without type 2 diabetes and obesity by Magnus F G Grøndahl, Jonatan I Bagger, Malte P Suppli, Gerrit Van Hall, Nicolai J W Albrechtsen, Jens J Holst, Tina Vilsbøll, Mikkel B Christensen, Asger B Lund, Filip K Knop

    Published in Endocrine Connections (2024-02-01)
    Get full text
    Article


  18. 18

    Correction: The effect of Mycobacterium tuberculosis treatment on thrombelastography-assessed haemostasis: a prospective cohort study by Hans Johan Niklas Lorentsson, Christina R. Clausen, Daniel Faurholt-Jepsen, Katrine Bagge Hansen, Sidse Graff Jensen, Rikke Krogh-Madsen, Per G. Hagelqvist, Pär I. Johansson, Tina Vilsbøll, Filip K. Knop, Pernille Ravn

    Published in Thrombosis Journal (2024-11-01)
    Get full text
    Article


  19. 19

    The effect of Mycobacterium tuberculosis treatment on thrombelastography-assessed haemostasis: a prospective cohort study by Hans Johan Niklas Lorentsson, Christina R. Clausen, Daniel Faurholt-Jepsen, Katrine Bagge Hansen, Sidse Graff Jensen, Rikke Krogh-Madsen, Per G. Hagelqvist, Pär I. Johansson, Tina Vilsbøll, Filip K. Knop, Pernille Ravn

    Published in Thrombosis Journal (2024-06-01)
    Get full text
    Article


  20. 20

    Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protoco... by Jimmi Nielsen, Christoph U Correll, Tina Vilsbøll, Maj Vinberg, Claus Ekstrøm, Anders Fink-Jensen, Heidi Storgaard, Filip K Knop, Ole Mors, Marie Reeberg Sass, Andreas Aalkjær Danielsen, Ole Köhler-Forsberg, Mette Ødegaard Nielsen, Anders Mikael Sjödin

    Published in BMJ Open (2023-01-01)
    Get full text
    Article


Search Tools: